Antibody and Agglutinin in Pneumococcus Pneumonia
نویسندگان
چکیده
1. Protective substances and agglutinins were not demonstrated in the blood of patients with pneumonia untreated with serum before the fall in the temperature by crisis or lysis. 2. Protective substances and agglutinins were frequently demonstrated in serum treated patients during the course of the disease. 3. Protective substances and agglutinins were usually present at the time of the temperature fall in patients untreated with serum and persisted for days or weeks thereafter. 4. Protective substances have an important bearing on the outcome. A large proportion of those with protection recover and a large proportion without it die. 5. Agglutinin and antibody may appear simultaneously or one may precede or be present without the other. 6. Tests for agglutinin are unreliable as a control of dosage of specific serum.
منابع مشابه
Certain Aspects of Mouse Protection Tests for Antibody in Pneumococcus Pneumonia
1. Though in general in pneumococcus pneumonia the appearance of protective substance coincides rather sharply with the fall in the temperature, antibody may appear spontaneously in the blood serum as early as the 3rd or 4th day and crisis and recovery may be delayed until the 6th to the 10th day. 2. Recovery at times occurs without demonstrable protective substance in the blood in patients who...
متن کاملSerological Reactions in Pneumonia with a Non-protein Somatic Fraction of Pneumococcus
1. Sera from individuals acutely ill with lobar pneumonia possess the capacity to precipitate in high titre a non-protein somatic fraction derived from pneumococci (Fraction C). Following crisis the reaction is no longer demonstrable. 2. Sera obtained from cases of pneumococcus pneumonia during illness and convalescence have been tested for antibodies specifically reactive with three chemically...
متن کاملA Note on the Specific Agglutination of Pneumococcus Types I, Ii and Iii
1. Type-specific agglutination of Pneumococcus Types I, II and III has been demonstrated in antisera largely deprived of the carbohydrate antibody. 2. The type-specific agglutinogens in Pneumococcus I and II responsible for agglutination in such antisera are inactivated by heating in alkaline solution at 100 degrees C. The specific carbohydrate remains unaltered under these conditions. 3. The r...
متن کاملAntibody Formation in Cases of Lobar Pneumonia Treated with Sulfathiazole.
Early in 1940'we published a report (1) on antibody formation in cases of lobar pneumonia treated with sulfapyridine. In nineteen treated cases of pneumococcus pneumonia repeatedly studied during the acute phase of the disease and during convalescence, an excess of type-specific antibody was only demonstrated in the serum of four. In the past it has often been shown that spontaneous recovery fr...
متن کاملجداسازی استرپتوکوکوس ویریدانس به عنوان عامل پنومونی در نمونههای برونکوآلوئولار لاواژ در بیماران مبتلا به پنومونی
Background: Pneumonia is one of the most important causes of death worldwide and its accurate diagnosis is extremely important. Typically, Viridans Streptococci are not the cause of pneumonia, but in patients with an underlying illness, they can be problematic. Also, due to contamination with the microbial flora of the upper respiratory tract, they may be isolates from a pure culture, which mak...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The Journal of Experimental Medicine
دوره 50 شماره
صفحات -
تاریخ انتشار 2003